Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-13 Purchase |
2024-05-15 07:04 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
30,000 | $5.47 | $164,100 | 307,533 (Direct) |
View |
| 2022-12-15 Sale |
2022-12-19 4:48 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
6,100 | $10.9 | $66,490 | 211,610 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-19 Tax Withholding |
2024-12-23 4:19 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
2,461 | $7.39 | 684,496 (Direct) |
View |
| 2024-12-19 Option Award |
2024-12-23 4:19 pm |
2025-12-19 2034-12-19 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
386,900 | $0 | 684,496 (Direct) |
View |
| 2024-12-14 Tax Withholding |
2024-12-17 4:22 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
8,251 | $7.53 | 300,057 (Direct) |
View |
| 2023-12-19 Tax Withholding |
2023-12-20 4:38 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
2,482 | $6.05 | 274,533 (Direct) |
View |
| 2023-12-14 Tax Withholding |
2023-12-18 4:40 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
5,840 | $6.43 | 435,515 (Direct) |
View |
| 2023-12-14 Option Award |
2023-12-18 4:40 pm |
2024-12-14 2033-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
192,500 | $0 | 435,515 (Direct) |
View |
| 2022-12-19 Option Award |
2022-12-21 4:34 pm |
2023-12-19 2032-12-19 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
192,500 | $0 | 404,110 (Direct) |
View |
| 2021-12-14 Option Award(A) |
2022-01-13 4:38 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
80,000 | $0 | 216,556 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 5:12 pm |
2022-12-14 2031-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
289,000 | $0 | 425,556 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-17 4:37 pm |
2021-12-15 2030-12-15 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Vice President and CCO |
190,000 | $0 | 190,000 (Direct) |
View |